Pfizer, Arvinas win FDA nod for first-of-its-kind breast cancer therapy

Pfizer Inc. PFE and partner Arvinas Inc. ARVN shares rose Monday after the companies secured a key regulatory win, with the U ...
BioSpace

FDA clears Pfizer, Arvinas’ novel breast cancer therapy despite mixed data

Veppanu, the first PROTAC therapy approved by the FDA, improved progression free survival by 43% versus AstraZeneca’s ...
Fierce Pharma

FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype

Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening ...

Pfizer pins post 2028 return to growth on new obesity and cancer drugs

By Mariam Sunny and Christy Santhosh May 5 (Reuters) - Pfizer said on Tuesday that it expects to return to stronger growth ...

MTS Health Partners Appoints Sally Susman as Senior Advisor

MTS Health Partners, L.P. (MTS), a leading investment bank dedicated to the healthcare industry, is thrilled to announce the appointment of Sally Susman as Senior Advisor. Ms. Susman, most recently ...